文献速递主动脉疾病

Medicare 受益者腹主动脉瘤腔内修复中不同支架移植物的比较

Comparison of Endovascular Stent Grafts for Abdominal Aortic Aneurysm Repair in Medicare Beneficiaries.
PubMed 文献 · Ann Vasc Surg · 2017-09-08

肾上固定支架围手术期死亡率、肾衰竭及肠系膜缺血率高于肾下固定支架,4 年再干预更少;一体式支架围手术期并发症及再干预更多,但转开放手术更少。

要点

  • 肾上固定支架围手术期死亡率、肾衰竭及肠系膜缺血率高于肾下固定支架。
  • 肾上固定支架 4 年再干预及转开放手术少于肾下固定支架,但死亡率略高。
  • 一体式支架围手术期肾衰竭、肠系膜缺血及再干预更多,转开放手术更少。

核心结论

  • 与肾下固定装置相比,肾上固定 EVAR 围手术期死亡率及肾脏并发症更高,但再干预包括转开放手术更少。
  • 一体式支架围手术期并发症及动脉瘤相关再干预更多,但转开放手术更少。
  • 晚期破裂在各组间无差异。
  • 作者指出差异可能由选择偏倚解释,建议进一步开展比较效果分析。

研究设计与样本

  • 肾上固定 11,002 例(24%),肾下固定 32,909 例(71%),一体式支架 2,260 例(5%)。
  • 采用倾向评分加权平衡各组患者特征,比较围手术期结局及 4 年生存、破裂和再干预率。

主要发现

  • 肾上固定组围手术期死亡率 1.7% vs 肾下固定组 1.3%(P < 0.01)。
  • 肾上固定组肾衰竭 6.0% vs 4.7%(P < 0.001),肠系膜缺血 0.7% vs 0.4%(P < 0.01),住院时间 3.4 天 vs 3.0 天(P < 0.001)。
  • 一体式支架组肾衰竭 5.9% vs 4.7%(P < 0.001),肠系膜缺血 1.0% vs 0.4%(P < 0.001),转开放手术 0.7% vs 0.1%(P < 0.001)。
  • 4 年时肾上固定组死亡率 30% vs 29%(P = 0.047),转开放手术 0.6% vs 0.9%(P = 0.03),动脉瘤相关再干预 10% vs 12%(P < 0.01)。
  • 4 年时一体式支架组动脉瘤相关干预 15% vs 12%(P < 0.01),转开放手术 0.4% vs 0.9%(P = 0.02);晚期破裂各组无差异。

临床怎么用

  • 选择肾上固定支架时需权衡较高的围手术期死亡及肾脏并发症风险与较低的远期再干预需求。
  • 一体式支架围手术期并发症及再干预较多,但转开放手术较少,宜个体化选择。
  • 解读差异时需考虑选择偏倚,尚需进一步比较效果分析验证。

局限性

  • 作者指出观察到的差异可能由选择偏倚解释。
  • 原文摘要未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Increased renal complications have been suggested with suprarenal stent grafts, but long-term analyses have been limited. Therefore, the purpose of this study was to evaluate the effect of endograft choice on perioperative and long-term outcomes. METHODS: We compared Medicare beneficiaries undergoing endovascular abdominal aortic aneurysms repair from 2005 to 2008 with endografts with infrarenal fixation and a single docking limb (AneuRx, Excluder) to those with suprarenal fixation and 2 docking limbs (Zenith), or a unibody configuration (Powerlink). Propensity score weighting accounted for differences in patient characteristics among the different graft formations, and perioperative mortality, complications, and length of stay and 4-year rates of survival, rupture, and reintervention were compared. RESULTS: Forty-six thousand one hundred seventy-one Medicare beneficiaries were identified including 11,002 (24%) with suprarenal fixation, 32,909 (71%) with infrarenal fixation, and 2,260 (5%) with a unibody graft. After propensity score weighting, there were no significant differences in patients' baseline clinical and demographic characteristics. The suprarenal fixation patients had higher rates of perioperative mortality (1.7% vs. 1.3%, P < 0.01), renal failure (6.0% vs. 4.7%, P < 0.001), and mesenteric ischemia (0.7% vs. 0.4%, P < 0.01) and longer length of stay (3.4 days vs. 3.0 days, P < 0.001) compared with patients with infrarenal fixation. Unibody grafts had higher rates of renal failure (5.9% vs. 4.7%, P < 0.001), mesenteric ischemia (1.0% vs. 0.4%, P < 0.001), and conversion to open repair (0.7% vs. 0.1%, P < 0.001) compared to those with infrarenal fixation and single docking limbs. At 4 years, mortality remained slightly higher with suprarenal compared to infrarenal fixation (30% vs. 29%, P = 0.047), although these patients had fewer conversions to open repair (0.6% vs. 0.9%, P = 0.03) and aneurysm-related reinterventions (10% vs. 12%, P < 0.01). At 4 years, unibody grafts had more aneurysm-related interventions compared to infrarenal fixation grafts (15% vs. 12%, P < 0.01) but fewer conversions to open repair (0.4% vs. 0.9%, P = 0.02). Late rupture did not differ among the groups. CONCLUSIONS: Compared to infrarenal fixation devices, patients who underwent EVAR with suprarenal fixation had higher perioperative mortality and renal complications but fewer reinterventions including conversion, while the unibody graft had more perioperative complications and aneurysm-related reinterventions, but fewer conversions to open repair. Although these differences could be explained by selection bias, these data suggest that further comparative effectiveness analyses should be performed to understand the outcomes following EVAR with suprarenal fixation and unibody grafts.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Buck DB, Soden PA, Deery SE, et al. Comparison of Endovascular Stent Grafts for Abdominal Aortic Aneurysm Repair in Medicare Beneficiaries. Ann Vasc Surg. 2017. PMID: 28890065. doi:10.1016/j.avsg.2017.08.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。